Trichomonas vaginalis |
calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative |
0.2168 |
0.4765 |
1 |
Trichomonas vaginalis |
rod cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.2168 |
0.4765 |
1 |
Mycobacterium tuberculosis |
Two component sensor histidine kinase DevS |
0.1959 |
0.4152 |
1 |
Loa Loa (eye worm) |
hypothetical protein |
0.3955 |
1 |
1 |
Toxoplasma gondii |
GAF domain-containing protein |
0.0542 |
0 |
0.5 |
Trypanosoma brucei |
GAF domain/TIP41-like family, putative |
0.1417 |
0.2566 |
1 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.1626 |
0.3178 |
0.667 |
Leishmania major |
hypothetical protein, conserved |
0.1417 |
0.2566 |
1 |
Trichomonas vaginalis |
rod cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cAMP-specific phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
conserved hypothetical protein |
0.2168 |
0.4765 |
1 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cone cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cAMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cGMP-dependent 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trypanosoma cruzi |
GAF domain/TIP41-like family, putative |
0.1417 |
0.2566 |
1 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Schistosoma mansoni |
cgmp-dependent 35-cyclic phosphodiesterase |
0.3955 |
1 |
1 |
Trichomonas vaginalis |
cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cGMP-dependent 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cAMP/cGMP cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cyclic nucleotide phosphodiesterase, putative |
0.2168 |
0.4765 |
1 |
Trichomonas vaginalis |
cyclic nucleotide phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Toxoplasma gondii |
hypothetical protein |
0.0542 |
0 |
0.5 |
Echinococcus multilocularis |
dual 3',5' cyclic AMP and GMP phosphodiesterase |
0.0751 |
0.0612 |
0.5 |
Echinococcus granulosus |
dual 3'5' cyclic AMP and GMP phosphodiesterase |
0.0751 |
0.0612 |
0.5 |
Trichomonas vaginalis |
cGMP-dependent 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Mycobacterium leprae |
conserved hypothetical protein |
0.0542 |
0 |
0.5 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Echinococcus multilocularis |
cAMP and cAMP inhibited cGMP 3',5' cyclic |
0.0751 |
0.0612 |
0.5 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.1626 |
0.3178 |
0.667 |
Trichomonas vaginalis |
cGMP-inhibited 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trichomonas vaginalis |
cAMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Mycobacterium ulcerans |
two component sensor histidine kinase DevS |
0.1959 |
0.4152 |
1 |
Trichomonas vaginalis |
cAMP-specific phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Toxoplasma gondii |
hypothetical protein |
0.0542 |
0 |
0.5 |
Trichomonas vaginalis |
cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Plasmodium vivax |
hypothetical protein, conserved |
0.0542 |
0 |
0.5 |
Mycobacterium tuberculosis |
Conserved hypothetical protein |
0.1417 |
0.2566 |
0.6179 |
Trichomonas vaginalis |
cone cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Trypanosoma cruzi |
GAF domain/TIP41-like family, putative |
0.1417 |
0.2566 |
1 |
Trichomonas vaginalis |
rod cGMP-specific 3,5-cyclic phosphodiesterase, putative |
0.0751 |
0.0612 |
0.1285 |
Plasmodium falciparum |
GAF domain-related protein, putative |
0.0542 |
0 |
0.5 |
Toxoplasma gondii |
hypothetical protein |
0.0542 |
0 |
0.5 |
Echinococcus granulosus |
cAMP and cAMP inhibited cGMP 3'5' cyclic |
0.0751 |
0.0612 |
0.5 |